Propanc Biopharma, Inc.

PPCB ·Healthcare, Drug Manufacturers - General, Australia
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
EFFECT Jan 9, 2026
8-K Jan 7, 2026 8-K
CORRESP Jan 6, 2026
UPLOAD Jan 5, 2026
S-1 Dec 30, 2025 S-1
DEF 14C Dec 29, 2025 DEF 14C
PRE 14C Dec 10, 2025 PRE 14C
SCHEDULE 13G/A Nov 14, 2025
10-Q Nov 14, 2025 10-Q
8-K Nov 10, 2025 8-K
8-K Oct 14, 2025 8-K
10-K Sep 29, 2025 10-K
8-K Aug 19, 2025 8-K
SCHEDULE 13G Aug 19, 2025
424B3 Aug 18, 2025 424B3
424B4 Aug 18, 2025 424B4
CERT Aug 14, 2025
EFFECT Aug 13, 2025
8-A12B Aug 13, 2025 8-A12B
8-K Aug 13, 2025 8-K
CORRESP Aug 12, 2025
CORRESP Aug 12, 2025
CORRESP Jul 31, 2025
CORRESP Jul 31, 2025
8-K Jul 30, 2025 8-K
← Newer Page 2 of 18 · 434 filings Older →